Cargando…
3-O-Methyldopa inhibits astrocyte-mediated dopaminergic neuroprotective effects of l-DOPA
BACKGROUND: We evaluated the effects of 3-O-methyldopa (3-OMD), a metabolite of l-DOPA which is formed by catechol-O-methyltransferase (COMT), on the uptake, metabolism, and neuroprotective effects of l-DOPA in striatal astrocytes. We examined changes in the numbers of dopaminergic neurons after tre...
Autores principales: | Asanuma, Masato, Miyazaki, Ikuko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960704/ https://www.ncbi.nlm.nih.gov/pubmed/27456338 http://dx.doi.org/10.1186/s12868-016-0289-0 |
Ejemplares similares
-
Mirtazapine exerts astrocyte-mediated dopaminergic neuroprotection
por: Kikuoka, Ryo, et al.
Publicado: (2020) -
Striatal Astrocytes Act as a Reservoir for L-DOPA
por: Asanuma, Masato, et al.
Publicado: (2014) -
Neuron-Astrocyte Interactions in Parkinson’s Disease
por: Miyazaki, Ikuko, et al.
Publicado: (2020) -
Region-Specific Neuroprotective Features of Astrocytes against Oxidative Stress Induced by 6-Hydroxydopamine
por: Asanuma, Masato, et al.
Publicado: (2019) -
Multifunctional Metallothioneins as a Target for Neuroprotection in Parkinson’s Disease
por: Miyazaki, Ikuko, et al.
Publicado: (2023)